RxDoctor Payments Data

Wendell Scott, MD

Ophthalmology · Springfield, MONPI 1710077151

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $39,850 of the $42,232 with a category attached, or 94.4%. Johnson & Johnson Surgical Vision, Inc. accounts for 97.8% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2020 at $14,108 and has fallen 97.9% since, to $294 in 2025. Among ophthalmology clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$42,232in general payments, 2019–2025

Across 101 payments — averaging $418.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson Surgical Vision, Inc.$41K
  • Glaukos Corporation$229
  • Carl Zeiss Meditec, Inc.$189
  • Sight Sciences, Inc.$106
  • Alcon$106
  • Rxsight Inc$104
  • plus $205 from 4 others
$99,751in research payments, 2019–2025

Across 15 payments — averaging $6650.06 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Johnson & Johnson Surgical Vision, Inc.$100K

What the payments were for

  • Consulting fees$39,85094%
  • Food & beverage$2,3826%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$42,232 in reported general payments places this provider in the 90th percentile of 286 ophthalmology providers in Missouri.

See all ophthalmology providers in Missouri

Medicare billing

Part B allowed, 2024
$338,330
Medicare patients
499
Services billed
1,933

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate89$2,338
Ketorolac Tromethamine70$1,496
Ofloxacin49$656
Latanoprost49$167
Tobramycin24$136
Brimonidine Tartrate26$119
Timolol Maleate12$62

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Springfield

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →